Probucol Suppresses Enterocytic Accumulation of Amyloid-β Induced by Saturated Fat and Cholesterol Feeding
Amyloid-β (Aβ) is secreted from lipogenic organs such as intestine and liver as an apolipoprotein of nascent triacylglycerol rich lipoproteins. Chronically elevated plasma Aβ may compromise cerebrovascular integrity and exacerbate amyloidosis—a hallmark feature of Alzheimer’s disease (AD). Probucol...
| Main Authors: | Pallebage-Gamarallage, Menuka, Galloway, Susan, Takechi, Ryusuke, Dhaliwal, Satvinder, Mamo, John |
|---|---|
| Format: | Journal Article |
| Published: |
Springer
2011
|
| Online Access: | http://hdl.handle.net/20.500.11937/36581 |
Similar Items
Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.
by: Galloway, Susan, et al.
Published: (2008)
by: Galloway, Susan, et al.
Published: (2008)
Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
by: Takechi, Ryu, et al.
Published: (2013)
by: Takechi, Ryu, et al.
Published: (2013)
The differential effects of fatty acids on enterocytic abundance of amyloid-beta
by: Galloway, Susan, et al.
Published: (2019)
by: Galloway, Susan, et al.
Published: (2019)
The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance
by: Galloway, Susan, et al.
Published: (2009)
by: Galloway, Susan, et al.
Published: (2009)
Effect of fatty acids on enterocytic beta-amyloid abundance: Possible aetiology in Alzheimer’s disease
by: Galloway, S., et al.
Published: (2008)
by: Galloway, S., et al.
Published: (2008)
The effect of exogenous cholesterol and lipid modulating agents on apolipoprotein B and amyloid-beta abundance in the absorptive epithelial cells of the small intestine
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2008)
Colocalisation of plasma derived apo B lipoproteins with cerebral proteoglycans in a transgenic-amyloid model of Alzheimer's disease
by: Lam, Virginie, et al.
Published: (2011)
by: Lam, Virginie, et al.
Published: (2011)
Long-term probucol therapy continues to suppress markers of neurovascular inflammation in a dietary induced model of cerebral capillary dysfunction
by: Takechi, Ryu, et al.
Published: (2014)
by: Takechi, Ryu, et al.
Published: (2014)
A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
Post-prandial lipid metabolism, lipid-modulating agents and cerebrovascular integrity: Implications for dementia risk
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
The Effect of Atorvastatin, Pravastatin and Ibuprofen on Dietary-Fat Induced Disturbances in Blood-Brain Barrier Function
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2010)
Enterocyte Beta Amyloid-Lipoprotein Homeostasis: Implications for Alzheimer's Disease Risk
by: Galloway, Susan
Published: (2015)
by: Galloway, Susan
Published: (2015)
Nutraceutical agents with anti-inflammatory properties prevent dietary saturated-fat induced disturbances in blood-brain barrier function in wild-type mice
by: Takechi, Ryusuke, et al.
Published: (2013)
by: Takechi, Ryusuke, et al.
Published: (2013)
Amyloid-beta colocalizes with apolipoprotein B in absorptive cells of the small intestine
by: Galloway, Susan, et al.
Published: (2009)
by: Galloway, Susan, et al.
Published: (2009)
Disruption of blood-brain barrier function by chronic intake of saturated fat and cholesterol : implications for Alzheimer’s disease risk
by: Takechi, Ryusuke
Published: (2010)
by: Takechi, Ryusuke
Published: (2010)
Differential effects of saturated fatty acid, monounsaturated fatty acid and polyunsaturated fatty acid on chylomicron metabolism in the small intestine
by: Galloway, S., et al.
Published: (2008)
by: Galloway, S., et al.
Published: (2008)
Restoration of dietary-fat induced blood-brain barrier dysfunction by anti-inflammatory lipid-modulating agents
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
by: Pallebage-Gamarallage, Menuka, et al.
Published: (2012)
Aging-Related Changes in Blood-Brain Barrier Integrity and the Effect of Dietary Fat
by: Takechi, Ryusuke, et al.
Published: (2012)
by: Takechi, Ryusuke, et al.
Published: (2012)
Differential effects of dietary fatty acids on the cerebral distribution of plasma-derived apo B lipoproteins with amyloid-beta
by: Takechi, Ryu, et al.
Published: (2010)
by: Takechi, Ryu, et al.
Published: (2010)
Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus
by: Takechi, Ryu, et al.
Published: (2008)
by: Takechi, Ryu, et al.
Published: (2008)
Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration
by: Mamo, J., et al.
Published: (2018)
by: Mamo, J., et al.
Published: (2018)
β-Amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding
by: Galloway, Susan, et al.
Published: (2007)
by: Galloway, Susan, et al.
Published: (2007)
Pharmacological modulation of dietary lipid-induced cerebral capillary dysfunction: Considerations for reducing risk for Alzheimer’s disease
by: Pallebage-Gamarallage, M., et al.
Published: (2015)
by: Pallebage-Gamarallage, M., et al.
Published: (2015)
Nicotine Attenuates Disruption of Blood-Brain Barrier Induced by Saturated-Fat Feeding in Wild-Type Mice.
by: Elahy, M., et al.
Published: (2015)
by: Elahy, M., et al.
Published: (2015)
Three-dimensional colocalization analysis of plasma-derived apolipoprotein B with amyloid plaques in APP/PS1 transgenic mice
by: Takechi, Ryu, et al.
Published: (2009)
by: Takechi, Ryu, et al.
Published: (2009)
Nutritional and pharmacological regulation of cerebral capillary function
by: Pallebage-Gamarallage, Menuka Madhavi Somapala
Published: (2012)
by: Pallebage-Gamarallage, Menuka Madhavi Somapala
Published: (2012)
The Influence of Cholesterol on β-cell Function
by: Ellison, Gaewyn Colleen
Published: (2019)
by: Ellison, Gaewyn Colleen
Published: (2019)
An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques
by: Mooranian, Armin, et al.
Published: (2019)
by: Mooranian, Armin, et al.
Published: (2019)
Peripheral Metabolism of Lipoprotein-amyloid Beta as a Risk Factor for
Diabetes-induced Alzheimer's Disease and the Therapeutic Effects of Probucol and its Analogue
by: Sharif, Arazu
Published: (2024)
by: Sharif, Arazu
Published: (2024)
The effects of long-term saturated fat enriched diets on the brain lipidome
by: Giles, C., et al.
Published: (2016)
by: Giles, C., et al.
Published: (2016)
Probucol prevents blood–brain barrier dysfunction and cognitive decline in mice maintained on pro-diabetic diet
by: Mamo, John, et al.
Published: (2018)
by: Mamo, John, et al.
Published: (2018)
Morphological and Proliferative Responses of Rat Microglia Cells to Lipopolysaccharide and Β-Amyloid
by: Badiei, Alireza
Published: (2008)
by: Badiei, Alireza
Published: (2008)
Thymoquinone prevents β-amyloid neurotoxicity in primary cultured cerebellar granule neurons
by: Ismail, Norsharina, et al.
Published: (2013)
by: Ismail, Norsharina, et al.
Published: (2013)
The impact of luteinizing hormone and testosterone on beta amyloid (Aß) accumulation: Animal and human clinical studies
by: Verdile, Giuseppe, et al.
Published: (2015)
by: Verdile, Giuseppe, et al.
Published: (2015)
The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects
by: Mooranian, Armin, et al.
Published: (2018)
by: Mooranian, Armin, et al.
Published: (2018)
Asymptomatic neurotoxicity of amyloid β-peptides (Aβ1-42 and Aβ25-35) on mouse embryonic stem cell-derived neural cells
by: Mansor, Nur Izzati, et al.
Published: (2020)
by: Mansor, Nur Izzati, et al.
Published: (2020)
Efficacy of probucol on cognitive function in Alzheimer's disease: study protocol for a double-blind, placebo-controlled, randomised phase II trial (PIA study).
by: Lam, Virginie, et al.
Published: (2022)
by: Lam, Virginie, et al.
Published: (2022)
Multitarget drug design strategy in Alzheimer’s disease: focus on cholinergic transmission and amyloid-β aggregation
by: Simioni, Elena, et al.
Published: (2017)
by: Simioni, Elena, et al.
Published: (2017)
Chylomicron amyloi-beta in the aetiology of Alzheimer's disease
by: Takechi, Ryu, et al.
Published: (2008)
by: Takechi, Ryu, et al.
Published: (2008)
Similar Items
-
Probucol Reduces Enterocytic Amyloid-beta Relative to Chylomicron Apolipoprotein B in Mice Chronically Fed Saturated Fats
by: Takechi, Ryu, et al.
Published: (2010) -
Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance.
by: Galloway, Susan, et al.
Published: (2008) -
Probucol prevents blood-brain barrier dysfunction in wild-type mice induced by saturated fat or cholesterol feeding
by: Takechi, Ryu, et al.
Published: (2013) -
The differential effects of fatty acids on enterocytic abundance of amyloid-beta
by: Galloway, Susan, et al.
Published: (2019) -
The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance
by: Galloway, Susan, et al.
Published: (2009)